Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma Via Targeting MGMT
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma Via Targeting MGMT
Authors
Keywords
-
Journal
NEUROMOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-21
DOI
10.1007/s12017-020-08592-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioblastoma vs temozolomide: can the red queen race be won?
- (2019) Anjali Arora et al. CANCER BIOLOGY & THERAPY
- Expression of miR‐486‐5p and its significance in lung squamous cell carcinoma
- (2019) Sheng Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1
- (2019) Sung-Tau Chou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multiple functions of m6A RNA methylation in cancer
- (2018) Yutian Pan et al. Journal of Hematology & Oncology
- MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis
- (2018) Min Jiang et al. Oncotarget
- FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation
- (2017) Ke Xu et al. ONCOLOGY REPORTS
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013
- (2016) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Current and future strategies for treatment of glioma
- (2016) Nancy Ann Oberheim Bush et al. NEUROSURGICAL REVIEW
- MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
- (2016) Amanda Shea et al. Cancer Medicine
- Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis
- (2016) Christopher L. Plaisier et al. Cell Systems
- Differential expression of miR200a-3p and miR21 in grade II–III and grade IV gliomas
- (2014) Yolande Berthois et al. CANCER BIOLOGY & THERAPY
- Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation
- (2014) Patrick T. Grogan et al. INVESTIGATIONAL NEW DRUGS
- Allicin: Chemistry and Biological Properties
- (2014) Jan Borlinghaus et al. MOLECULES
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo
- (2013) Adarsh Shankar et al. Chinese Journal of Cancer
- Allicin Induces p53-Mediated Autophagy in Hep G2 Human Liver Cancer Cells
- (2012) Yung-Lin Chu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents
- (2012) Monika Szeliga et al. JOURNAL OF NEUROCHEMISTRY
- Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma
- (2010) Noriyuki Omura et al. CANCER BIOLOGY & THERAPY
- MicroRNAs in Cancer: Small Molecules With a Huge Impact
- (2009) Marilena V. Iorio et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started